Health, pharma and science writer at Reuters. Any opinions are mine.

Europe gets Amgen cholesterol drug for 50-60 pct of U.S. price

dailymail.co.uk — LONDON, Sept 1 (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.

Europe gets Amgen cholesterol drug for 50-60 percent of U.S. price

businessinsider.com — By Ben Hirschler LONDON (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.

Europe gets Amgen cholesterol drug for 50-60 pct of U.S. price

reuters.com — Repatha launches in Britain at just under half U.S. price * Cost in Austria and Finland around 60 pct of U.S. level * European cardiologists see cautious uptake initially By Ben Hirschler LONDON, Sept 1 (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S.

Europe gets Amgen cholesterol drug for 50-60 percent of U.S. price

uk.reuters.com — LONDON Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.

UPDATE 1-Bayer heart failure drug cuts deaths in mid-stage trial

reuters.com — Stress biomarker similar with finerenone vs older drug * Bayer moving experimental drug into final-stage testing * May launch in 2020/21, analysts see potential $2 bln sales (Updates with comment from lead investigator) By Ben Hirschler and Ludwig Burger Aug 31 (Reuters) - Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a "striking" reduction in deaths in a mid-stage trial.

Bayer moves heart drug to final tests after mid-stage success

reuters.com — Having done well with recently launched drugs like stroke prevention pill Xarelto and eye treatment Eylea, the German group is eager to show it has another potential billion-dollar-plus winner in finerenone. Finerenone, which is still several years from reaching the market, is an improved version of an troublesome class of heart drugs called mineralocorticoid receptor antagonists (MRAs).

Bayer moves heart drug to final tests after mid-stage success

businessinsider.com — By Ludwig Burger and Ben Hirschler (Reuters) - Bayer will move a new heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular medicine, after the experimental medicine proved better than an older rival in a mid-stage trial.

Bayer moves heart drug to final tests after mid-stage success

reuters.com — Having done well with recently launched drugs like stroke prevention pill Xarelto and eye treatment Eylea, the German group is eager to show it has another potential billion-dollar-plus winner in finerenone. Finerenone, which is still several years from reaching the market, is an improved version of an troublesome class of heart drugs called mineralocorticoid receptor antagonists (MRAs).

Alnylam, Medicines cholesterol drug lasts months after one shot

reuters.com — Results with Alnylam Pharmaceuticals and Medicines Co's experimental product ALN-PCSsc highlight the competition for a market tipped to generate billions of dollars in sales. Unlike rival antibody-based PCSK9 medicines that work in the blood, the new under-the-skin injection is a first-in-class treatment that stops synthesis of the protein which is linked to "bad" LDL cholesterol in the liver.

Alnylam, Medicines cholesterol drug lasts months after one shot

businessinsider.com — By Ben Hirschler LONDON (Reuters) - A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest.
More Articles →
Aug 29, 2015

New European #heart guidelines okay longer use of blood thinners (as well as shortened therapy in some cases) reut.rs/1i9A2HK #ESC15


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.